The Facts
Breast cancer impacts lives far beyond the individual—it touches families, communities, and the entire health system.
Breast cancer accounts for nearly
32%
of newly diagnosed cancers in women, making it the most common cancer among Women in the U.S.
1 in 8
women in the U.S. will face breast cancer in her lifetime.
There are estimated to be more than
168,000
people in the U.S. living with metastatic breast cancer.
Despite advances in detection and treatment, about
43,000
women and men are expected to die from the disease in 2025.
And disparities remain stark.
- Black women face a 40% higher mortality rate than white women.
- Hispanic women are less likely to be diagnosed early.
- Breast cancer is the most common cancer in American Indian and Alaska Native (AIAN) women.
- Compared to women, men are more likely to be diagnosed with distant-stage disease.
- Rural communities often lack access to quality care.
These gaps in care underscore the urgent need for solutions that improve outcomes for all.
Our Mission
To confront these challenges head-on, Susan G. Komen’s Center for Public Policy launched the Alliance for Breast Cancer Policy—a collaborative space where stakeholders unite to shape federal policy, share knowledge and advocate for change.
Since its launch, the Alliance has aligned stakeholders on policy solutions, advanced discussions on Capitol Hill, commissioned national research, and amplified advocacy through media and digital platforms. The Alliance members are driving progress toward equitable, affordable and high-quality breast cancer care for every patient.
The Alliance and its members work together to advance federal policy solutions that improve access to care for breast cancer patients across the continuum. Current key priorities include passage of the Access to Breast Cancer Diagnosis Act and federal data collection for metastatic breast cancer.
Our Priorities
The Alliance’s current legislative priority is building awareness and support for the Access to Breast Cancer Diagnosis, or ABCD, Act. The bipartisan, bicameral legislation requires private health plans to cover diagnostic and supplemental breast imaging – with no out-of-pocket costs for patients.
The Alliance also prioritizes efforts to accurately capture the scope and experiences of people living with metastatic breast cancer (MBC). By working with regulatory and scientific agencies to improve data collection and ensure every individual with metastatic disease is counted, the Alliance aims to better equip policymakers to improve treatment access, invest in research and improve outcomes for this community.
Contact Us
Complete the form below, and a member of our team will reach out to you soon.
Our Members
Steering Committee
Members
Founding Partner
Associate Partner
